Clinical Trials Browser

Advanced Solid Tumor × pembrolizumab × 90 days × Clear all

NCT06470763 2026-04-14

EXPAND-1

Phase 1/2 Active not recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT07182591 2026-03-20

A Study of DS5361b in Participants With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced Solid Tumor